glp 1 research GLP‑1 Receptor Agonists and Preclinical Assay Strategies Frontiers | GLP-1R in diabetes

For weight management, medications such as semaglutide (Wegovy) are licensed for adults with a BMI of 30 kg/m or above, or 27 kg/m with weight-related comorbidities

Effects of Glucagon-Like Peptide 1 on Counterregulatory Hormone Responses, Cognitive Functions, and Insulin Secretion during Hyperinsulinemic, Stepped Hypoglycemic Clamp Experiments in Healthy Volunteers

The primary mechanism of action involves binding to GLP-1 receptors located throughout the body, including the pancreas, brain, and gastrointestinal tract

doi: 10.1111/apt.17598

You can see our take on that evidence here

Ragasa may not turn to GLP-1s for her patients who want to lose weight